Drug, enzyme and peptide delivery using erythrocytes as carriers
- 25 February 2004
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 95 (1), 27-49
- https://doi.org/10.1016/j.jconrel.2003.11.018
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Mouse erythrocytes as carriers for coencapsulated alcohol and aldehyde dehydrogenase obtained by electroporation: In vivo survival rate in circulation, organ distribution and ethanol degradationLife Sciences, 2001
- Azidothymidine Homodinucleotide-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiretroviral Drug AzidothymidineBiochemical and Biophysical Research Communications, 1996
- FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5′-triphosphateVeterinary Immunology and Immunopathology, 1995
- Anomeric preference of glucose utilization in human erythrocytes loaded with glucokinaseBiochemical and Biophysical Research Communications, 1990
- Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivityBiochemical and Biophysical Research Communications, 1989
- In vitro stability of insulin-loaded erythrocytes after freezing storage.Journal of Pharmacobio-Dynamics, 1989
- The role of multivalency in antibody mediated liposome targetingBiochemical and Biophysical Research Communications, 1987
- Encapsulation of human urokinase in rabbit erythrocytes and its disposition in the circulation system in rabbits.Journal of Pharmacobio-Dynamics, 1987
- An efficient method for introducing macromolecules into living cells.The Journal of cell biology, 1985
- Incorporation of inositol hexaphosphate into red blood cells mediated by dimethyl sulfoxideLife Sciences, 1983